Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)
Expanded access is no longer available for this treatment.
Study NCT01026376 Information provided by Janssen-Cilag Farmaceutica Ltda.
First Received on December 3, 2009. Last Updated on April 17, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Bone Marrow Diseases
Interventions listed in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Janssen-Cilag Farmaceutica Ltda.
Janssen Korea, Ltd., Korea
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers